Komori
Share Issuance and Disposal4571Nano Holdings,Inc.Pharmaceuticals

Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions)

In relation to the 22nd Series of Stock Acquisition Rights, 315,000 shares were issued and 3,150 rights were exercised in June 2026. The number of outstanding unexercised rights at month-end was 268,250.

Worth reading
63In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
315000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause

発行・処分する株式数315,000Shares

315,000 shares (new shares); treasury shares transferred: —

発行済株式総数

0.44% (exercise ratio subject to exercise restrictions)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥94–¥112 per share during the month under review. Details of the adjustment clause and the floor are Not disclosed
Number of Stock Acquisition Rights
Approximately 370,588 rights in total (exact figure Not disclosed because it cannot be calculated from the statement that 3,150 rights represented 0.85% of the total issued rights); 271,400 unexercised rights at the end of the previous month and 268,250 at month-end
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
The 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025
Details of issuance or disposal
ItemDetails
Type of issuance or disposalMonthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
Number of shares to be issued or disposed of315,000 shares (new shares); treasury shares transferred: —
Dilution Rate0.44% (exercise ratio subject to exercise restrictions)
Total number of issued shares83,221,758 shares (as of the end of the month preceding the month under review) → Not disclosed
Exercise price¥94–¥112 per share during the month under review. Details of the adjustment clause and the floor are Not disclosed
Number of Stock Acquisition RightsApproximately 370,588 rights in total (exact figure Not disclosed because it cannot be calculated from the statement that 3,150 rights represented 0.85% of the total issued rights); 271,400 unexercised rights at the end of the previous month and 268,250 at month-end
Procedures under the Corporate Code of ConductThe disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financingThe 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status for June 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions) | Nano Holdings,Inc. (4571) timely disclosure | Komori